Papers
6
Total Citations
167
H-Index
6
About
Amelio Ercolino is a leading urologic surgeon and researcher whose work centers on optimizing surgical outcomes for kidney and bladder cancers. His major contributions lie in refining minimally invasive techniques—particularly robotic and laparoscopic surgery—to improve patient recovery and oncologic control. Ercolino developed a clinical nomogram to predict “trifecta” outcomes (negative margins, no complications, warm ischemia time ≤25 min) after partial nephrectomy, a tool that has guided surgical decision-making for localized renal masses (53 citations). He also pioneered the use of augmented reality for selective clamping and tumor dissection during robot-assisted partial nephrectomy, advancing precision in nephron-sparing surgery (50 citations). In comparative effectiveness research, his propensity score-matched analysis demonstrated that partial nephrectomy offers superior oncologic outcomes over percutaneous ablation for cT1a renal tumors (27 citations). Ercolino further led the Italian Radical Cystectomy Registry (RIC), a multicenter study comparing robotic, laparoscopic, and open cystectomy for bladder cancer, with over 1,400 patients enrolled. His work on ERAS protocols showed that robotic surgery significantly enhances recovery after radical cystectomy. With over 160 citations across his top papers, Ercolino’s research directly shapes clinical guidelines and surgical practice in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6